Bedel Financial Consulting, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,0000.0%380.0%0.00%
Q3 2021$1,000
-50.0%
380.0%0.00%
-100.0%
Q2 2021$2,0000.0%380.0%0.00%0.0%
Q1 2021$2,0000.0%380.0%0.00%0.0%
Q4 2020$2,0000.0%380.0%0.00%0.0%
Q3 2020$2,0000.0%380.0%0.00%0.0%
Q2 2020$2,000
-71.4%
38
-72.5%
0.00%
-80.0%
Q1 2020$7,000
+250.0%
138
+263.2%
0.01%
+400.0%
Q4 2019$2,0000.0%380.0%0.00%0.0%
Q3 2019$2,000380.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders